The aims of this review are to describe some of the main factors regulating UCP1 activity in brown and brite adipocytes, as well as to discuss the potential role of UCP1 activation for the treatment of insulin resistance and type 2 diabetes associated with obesity. The gene discussed is UCP1; the disease is obesity due to melanocortin 4 receptor deficiency.